April 2026

Cambium Bio has clinched FDA agreement on a streamlined single pivotal Phase 3 trial for Elate Ocular®, cutting development complexity, while bolstering its cash position through a A$2.4 million strategic placement by major shareholder ZYBT.

Orthocell’s latest Remplir™ Real World Evidence study reveals an 89.7% treatment success rate across 78 nerve repair procedures, reinforcing its clinical strength and fueling US and European market growth plans.

Mammoth Minerals reported significant shallow gold intercepts at its Excelsior Springs project in Nevada, expanded its landholding with the Imperial Gold Project acquisition, and completed the Paterson divestment, positioning itself for further exploration growth.

dorsaVi is pivoting from wearable sensors to powering next-gen exoskeletons, leveraging its neuromorphic RRAM technology to tap a projected $2 billion market by 2033.

Recharge Metals has kicked off exploration at its Sunset Well Gold Project in WA, backed by a $6 million war chest and a leadership reshuffle bringing in geologist Luke Timmermans as CEO.

New Age Exploration (ASX: NAE) has confirmed high-grade gold mineralisation consistent with Hemi-style intrusion at its Wagyu Gold Project in Western Australia, while also expanding its footprint through the acquisition of the Wallah Silver Project in NSW and progressing drilling in New Zealand.

Kingston Resources has brought forward copper concentrate production at Mineral Hill by a quarter, successfully trialing underground ore processing and advancing its multi-commodity strategy.

Australian Mines Limited's latest scoping study for its Flemington Scandium Project reveals strong financial metrics and significant upside potential tied to scandium pricing, underscoring the project's strategic position in critical minerals.

Venari Minerals has achieved a key metallurgical milestone by producing 99.5% pure battery-grade lithium carbonate from its Red Mountain Project in Nevada, highlighting its potential as a domestic US lithium chemical source alongside valuable by-products.

Proteomics International is pivoting from research to disciplined commercial execution of its proteomics-based diagnostic tests, focusing on distributor partnerships and reimbursement pathways in Australia and the US.

Power Minerals confirms exceptionally high-grade rare earth oxide assays at its newly acquired Morro do Ferro Project in Brazil, validating historical data and setting the stage for aggressive drilling and resource definition.

Golden Horse Minerals delivered robust drilling results at Southern Cross in Q1 2026, including visible gold at depth and strong shallow intercepts, supported by a healthy cash reserve of $39.3 million.

Stakk Ltd has reported a striking 186% quarter-on-quarter revenue jump to A$5.52 million in Q1 2026, driven by converting contracted clients into active billing and new engagements, underpinning strong recurring revenue and cash flow.

St George Mining has expanded its Araxá rare earths-niobium resource by 75% to 70.91Mt at 4.06% TREO, positioning the project among the world’s largest carbonatite deposits. The company also acquired land for processing facilities and forged new downstream partnerships, supported by Minas Gerais state tax incentives.

LTR Pharma has wrapped up recruitment for its SPONTAN Phase II pharmacokinetic study, with interim results expected soon to bolster FDA approval efforts. Meanwhile, US commercial talks for ROXUS advance cautiously under the FDA 503(a) personalised medicine pathway.

Resolution Minerals has successfully produced high-grade tungsten concentrates from historical stockpiles at its Golden Gate mine, achieving a 19-fold upgrade and strong recovery rates using simple gravity separation techniques.

Hammer Metals has kicked off a Reverse Circulation drilling campaign at its Mount Isa Kalman project, aiming to upgrade inferred copper-gold resources and expand near-surface mineralisation. The program supports an upcoming Scoping Study and reflects optimism due to recent strength in copper, molybdenum, and rhenium prices.

Catalina Resources has broadened its exploration footprint at Beasley Creek, unveiling multiple new copper-gold-silver targets along a key structural corridor and securing $180,000 in Western Australian government funding to kickstart drilling.

European Resources has more than doubled its Korsnäs rare earth resource following a successful drilling program and metallurgical advances, underpinning a $3.4 million capital raise to fund further development.

True North Copper has kicked off a major 2026 drilling campaign at its Mt Oxide Project, aiming to extend the Aquila copper-cobalt-silver discovery and advance resource growth across the district.

INOVIQ Limited is on track to complete its EXO-OC™ ovarian cancer screening study by mid-2026 and is accelerating its CAR-exosome therapy program, supported by a strong cash position of A$11.9 million.

Streamplay Studio delivers a fourth consecutive quarter of positive cash flow, underpinned by steady publishing revenues and strategic platform growth in new regions.

Echo IQ has taken a major step in its US expansion by deploying its AI-powered EchoSolv AS software at Mount Sinai Health System, one of America’s leading cardiovascular centres. This marks a key milestone in integrating AI into routine cardiology workflows at scale.

First Graphene has secured advanced graphene coatings technology through the AU$250,000 acquisition of Ionic Industries and Imagine Intelligent Materials, gaining immediate entry into lucrative geotextile and environmental infrastructure sectors.